Patent: 5,693,027
✉ Email this page to a colleague
Summary for Patent: 5,693,027
| Title: | Adaptor top |
| Abstract: | A plastic top for adapting to a chosen syringe (14) a standard cartridge (8) of the kind having a neck (9) with a flange (10) and being closed by a rubber membrane (11) sealingly secured against the flange (10) by a metal cover (12) having its edge beaded behind the flange. This plastic top has a bore (2) for receiving the neck part (9) of the cartridge (8), which bore (2) has a diameter making it fit over the metal cover (12) and is provided with protrusions (3;9) gripping behind the edge of the metal cover (12) when the neck part (9) is inserted in the bore. The outer contour of the plastic top is adapted to the syringe type in which the cartridge is going to be used. The plastic top is provided with a thread (5;18) coaxial with the bore to receive a needle hub (13) in a way making its needle (15) penetrate the membrane (11) of the cartridge (8) when the hub (13) is mounted on the thread (5) of the plastic top. |
| Inventor(s): | Hansen; Ib (Herlev, DK), Mikkelsen; S.o slashed.ren (Holte, DK), Bonnichsen; Frits Frydendal (Lynge, DK) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 08/313,651 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,693,027
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | June 25, 1991 | ⤷ Subscribe | 2014-12-02 |
| Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | June 01, 2018 | ⤷ Subscribe | 2014-12-02 |
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | June 07, 2000 | ⤷ Subscribe | 2014-12-02 |
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | January 19, 2001 | ⤷ Subscribe | 2014-12-02 |
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | April 23, 2004 | ⤷ Subscribe | 2014-12-02 |
| Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | October 31, 2013 | ⤷ Subscribe | 2014-12-02 |
| Novo Nordisk Inc. | NOVOLOG MIX 70/30 | insulin aspart protamine and insulin aspart | Injectable Suspension | 021172 | November 01, 2001 | ⤷ Subscribe | 2014-12-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,693,027
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 908598 | ⤷ Subscribe |
| Yugoslavia | 47778 | ⤷ Subscribe |
| Yugoslavia | 205890 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 9204927 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 9204926 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 9106333 | ⤷ Subscribe |
| United States of America | D347894 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
